CY2017021I2
(en )
2017-11-14
HIGH Affinity HUMAN ANTIBODIES TO PCSK9
ZA201101818B
(en )
2012-05-30
Modified release emulsions for application to skin or viginal mucosa
BRPI0910124A2
(en )
2015-12-29
"temporary tattoo decals to detect the presence of an analyte"
BRPI0914630A2
(en )
2019-09-24
dermal release
BRPI0912213A2
(en )
2015-10-06
cosmetic preparation
BRPI0909954A2
(en )
2015-11-03
"diazacarbazoles and methods of use"
BRPI0814876A2
(en )
2014-09-30
PHOSPHORILATED PYRONA ANALOGS AND METHODS
DOP2009000144A
(en )
2009-07-30
COMPOSITION OF SUSTAINED RELEASE AND METHODS TO PRODUCE THE SAME
BRPI0913337A2
(en )
2017-05-23
pulsatile release of valsartan
BRPI0811132A2
(en )
2014-12-23
PREPARATION OF PALADIO-GOLD CATALYZERS
DK2173366T3
(en )
2013-07-22
USE OF BIGIFT TO TREAT PARKINSON'S DISEASE
BRPI0909840A2
(en )
2015-07-28
Use of 4-thio-2-deoxynucleosides
DE602008005536D1
(en )
2011-04-28
Preparation of MnB12H12
DK2121142T3
(en )
2013-07-29
Use of GDF-5 to improve or maintain the appearance of the skin
BRPI0714318A2
(en )
2014-06-24
USE OF 2-BENZOIL-IMIDAZOPYRIDINS IN THERAPEUTIC
FR2932986B1
(en )
2010-12-10
REGENERATING COMPOSITION OF THE SKIN
DK2173197T3
(en )
2019-09-23
Course of action
MA30860B1
(en )
2009-11-02
MYRTILLIER DENOMME "C97-390"
BRPI0917541A2
(en )
2015-11-17
use of soforicoside in the manufacture of medicines
GB0609797D0
(en )
2006-06-28
Adhesive solution for application to the skin
TH0601001328A
(en )
2015-08-03
Enhancing the release of beneficial substances to the skin
BRPI0922008A2
(en )
2016-05-10
compounds and their preparation methods
DK2310037T3
(en )
2014-10-27
CONGLUTIN-GAMMA AS-MEDICINE AND COST-SUPPLEMENT PATENT REQUIREMENTS
FR2938435B1
(en )
2012-05-25
HYPOALLERGENIC DERMATOLOGICAL COMPOSITION
FI20085971A0
(en )
2008-10-15
Use of betaine